Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Advanced Medical Inc.

This article was originally published in The Gray Sheet

Executive Summary

Advanced Medical Inc.: Firm's Imed subsidiary enters an agreement to re-acquire European marketing rights to its intravenous infusion pumps and related disposable administration sets from Pharmacia & Upjohn, whose Kabi Pharmacia unit has distributed the products under a 1991 deal. Under the new agreement, expected to close by Aug. 30, 1996, Imed will pay roughly $11 mil. for the European distribution business. "On an annualized basis, we expect this transaction to increase sales and operating income by approximately $7 mil. and $2.5 mil., respectively," Advanced Medical says. Separately, Advanced Medical acquires from GE Capital a warrant to purchase, "for a nominal amount," 10% of Imed's outstanding common stock. American Medical pays $12.5 mil. for the warrant, which was issued to GE Capital in 1990 in connection with a leveraged buyout of Imed...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel